The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms. - Wikidata - awgldk - TriplyDB

The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms.

The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms.

http://www.wikidata.org/entity/Q34770421

about

The inhibition of the highly expressed miR-221 and miR-222 impairs the growth of prostate carcinoma xenografts in mice The functional significance of microRNA-145 in prostate cancer Molecular biology of lung cancer: clinical implications MicroRNAs: control and loss of control in human physiology and disease Clinical relevance of SKP2 alterations in metastatic melanoma Searching for the 'melano-miRs': miR-214 drives melanoma metastasis AngiomiRs--key regulators of angiogenesis MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation MicroRNA-221-222 regulate the cell cycle in mast cells The miR-200 and miR-221/222 microRNA families: opposing effects on epithelial identity Role of microRNAs in hepatocellular carcinoma: a clinical perspective A Variant in a MicroRNA complementary site in the 3' UTR of the KIT oncogene increases risk of acral melanoma MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality Constitutive activation of the ETS-1-miR-222 circuitry in metastatic melanoma Characterization of the Melanoma miRNAome by Deep Sequencing Control by a hair's breadth: the role of microRNAs in the skin The elephant in the room: do microRNA-based therapies have a realistic chance of succeeding for brain tumors such as glioblastoma?RNA Genes: Retroelements and Virally Retroposable microRNAs in Human Embryonic Stem Cells.Genome-wide analysis of promoter methylation associated with gene expression profile in pancreatic adenocarcinoma.Zinc finger protein ZBTB20 expression is increased in hepatocellular carcinoma and associated with poor prognosis.MicroRNA-221 and -222 pathway controls melanoma progression.Pre-micro RNA signatures delineate stages of endothelial cell transformation in Kaposi sarcoma.Conserved expression patterns predict microRNA targets The expression and functions of microRNAs in pancreatic adenocarcinoma and hepatocellular carcinoma Control of hepatic gluconeogenesis by the promyelocytic leukemia zinc finger protein.The regulation of miRNA-211 expression and its role in melanoma cell invasiveness.Regulation of cancer aggressive features in melanoma cells by microRNAs.microRNAs and lung cancer: tumors and 22-mers.microRNA and cancer Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategies Epigenetic regulation of microRNA genes and the role of miR-34b in cell invasion and motility in human melanoma Mutagen-specific mutation signature determines global microRNA binding.Micromarkers: miRNAs in cancer diagnosis and prognosis.Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression.MiR-221 promotes trastuzumab-resistance and metastasis in HER2-positive breast cancers by targeting PTEN.Correlation between Slug transcription factor and miR-221 in MDA-MB-231 breast cancer cells.The role of microRNAs and long non-coding RNAs in the pathology, diagnosis, and management of melanoma Clinical implications of microRNAs in cancer.

P2860

Q21562496-DB10AE64-084A-49AE-A479-713C8886A82C Q24606503-20817FF8-F85C-47C9-8137-180D1C97F23E Q24610335-B52E3A4E-A97B-439C-9E20-19C250510828 Q24618771-ED7143A0-7475-405D-910F-45CFC1E0C478 Q24630149-6016B6DA-BBF8-457B-8B7D-A9C4D1D5F06E Q24632823-2AC89425-05DC-40E2-9B39-D5D4507A1326 Q24645570-C2D8A2F1-7455-411C-8C7D-63926BCFC6CF Q24645663-4AB921B6-0502-4E1C-BAE4-6ED40D961B67 Q24650572-AF3C81F6-0E1D-4172-A8EB-1E15E67BEE64 Q24655473-58E3A3D0-572D-4A6D-8999-F0AF61A856D4 Q24656557-E4D5A3D0-336C-4A00-B6B6-E642D0B56075 Q27010233-60A5D59D-CDFB-48BA-BD63-C41EFE7B0B2F Q27014034-77C45459-30A7-43D7-9C7B-E289D8498D5D Q27851611-26796342-738F-4938-9BD0-E5554002F09F Q28115464-3FF2BA9F-070B-425B-A21A-8855ACBDCA4D Q28116578-4B833676-4C3E-40AD-9A13-BC03EBCA9820 Q28473165-E981741B-F503-4640-8760-2E6939D00146 Q28709944-6BA4D4F4-5268-4F09-9C33-9FD924D18403 Q30426792-636FFE48-8F24-4F92-84CA-9FB46F1E5A98 Q30496496-F92E9B6F-C8E0-4B00-ABFA-9C46ABFA0427 Q30502257-F3FF0CAA-16AE-4471-9CAC-A4221B06B412 Q31021133-C8F4661B-8D8A-42C8-B726-612B570CA19C Q33382465-E76F8CAC-06F6-4883-B90B-3D75E99E3B61 Q33432690-D153596E-6BB1-482A-8479-92EDEB366C5A Q33506599-5EA6E92D-7E3B-44AE-B1AE-14C780BD55D8 Q33579675-29177E4B-B8B7-4459-BC2F-51A0BC9431D4 Q33631885-618624B1-D1FF-40DA-98D5-9007E6862182 Q33745034-54AC113B-E29F-419D-A431-359EE1A8A714 Q33889489-873F5B8D-6E8A-480A-9C3A-70BC201D7B05 Q33910328-BE6267E1-6D09-4305-AAE9-FB173B9C5FD2 Q33954625-345FFEBB-C78E-4E41-B27D-7DCF4BEF0003 Q33980682-CDF407F9-7B07-4EE0-8BDE-B75A0E30E8E9 Q34031613-D160B432-A72C-474A-ADB6-CA3CDEF7D50A Q34077879-9B6CD67F-7030-4F73-BA78-BA0A313E7BD5 Q34108602-E65CC577-E07A-4263-8A6B-8DDB47A1134D Q34140780-75F55607-E4F3-47E7-B1B7-7E3BB5E68F38 Q34179919-F1C321F0-A49A-4089-8BBD-CAE90FB13089 Q34432552-D832E6F5-091F-4EAB-9499-9E70ECB1509F Q34459058-0C033AA9-25D5-4099-B679-0A8A75B3D61D Q34570698-962F5457-4A55-4120-BCC2-B7D8464B76BC

P2860

The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms.

http://www.wikidata.org/entity/Q34770421

description

2008 nî lūn-bûn

@nan

2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

The promyelocytic leukemia zin ...... multiple oncogenic mechanisms.

@ast

The promyelocytic leukemia zin ...... multiple oncogenic mechanisms.

@en

The promyelocytic leukemia zin ...... multiple oncogenic mechanisms.

@nl

type

label

The promyelocytic leukemia zin ...... multiple oncogenic mechanisms.

@ast

The promyelocytic leukemia zin ...... multiple oncogenic mechanisms.

@en

The promyelocytic leukemia zin ...... multiple oncogenic mechanisms.

@nl

prefLabel

The promyelocytic leukemia zin ...... multiple oncogenic mechanisms.

@ast

The promyelocytic leukemia zin ...... multiple oncogenic mechanisms.

@en

The promyelocytic leukemia zin ...... multiple oncogenic mechanisms.

@nl

P1433

Q34770421-6DD611B9-39DF-490F-AD0C-BFFCB6C5FF00

P1476

Q34770421-00E0355D-170F-4F5B-A39D-CA5451ADEBFE

P2093

Q34770421-32D53360-44F3-4134-8B2F-B9F33ECDA4DD

Q34770421-5118C9CB-074C-4190-94B3-AD49023E0881

Q34770421-6440611F-B5C0-4D4A-9C9E-58244F0CC274

Q34770421-6DCE0083-CB6C-452B-B93D-069DDFAAB280

Q34770421-92CF5F78-70C9-46DD-8920-77F359A0E724

Q34770421-99298942-4D57-43D2-A493-1D015E47AB19

Q34770421-A5DC692B-EC33-4E09-A816-9CA5B91E4D23

Q34770421-DAA054CE-672B-4D8D-B6B5-E1B8E69AF3E5

Q34770421-DB0A7E1B-D838-44CE-B4BF-D5D1FA763087

Q34770421-DB8621E1-A0EA-4B04-B285-9BCCFA8DBFF8

P304

Q34770421-0C1D6AFC-6216-45EE-BE33-61FB41BA4607

P31

Q34770421-D8E0E2DC-5E83-424F-A08B-88290A2A1FC3

P356

Q34770421-D76EA58C-90BD-4CA2-BA39-AEECBFF3282F

P407

Q34770421-8EB40DA5-5C14-41C5-9B4E-7A0BC17E6C6E

P433

Q34770421-C5D201D0-1E7D-42CD-B78D-E989F79F290C

P478

Q34770421-7DD4858B-E1DE-495B-910F-3776BEB78632

P577

Q34770421-8514F68E-4C9E-4859-9D85-EE89710FFEE2

P5875

Q34770421-B1D2F1CC-DE60-4DAE-A834-11BBF81A2376

P698

Q34770421-D9A78C7E-43BB-465D-BEE7-E3CB51420606

P921

Q34770421-C9A24D13-0F63-4341-B299-296F264393EF

Q34770421-EE637D43-406D-4393-B7FC-85B6F4BD9535

P356

0008-5472.CAN-07-2538

P1433

Cancer Research

P1476

The promyelocytic leukemia zin ...... multiple oncogenic mechanisms.

@en

P2093

Alessandra Carè

http://www.w3.org/2001/XMLSchema#string

Antonella Stoppacciaro

http://www.w3.org/2001/XMLSchema#string

Cesare Peschle

http://www.w3.org/2001/XMLSchema#string

Federica Felicetti

http://www.w3.org/2001/XMLSchema#string

Gianfranco Mattia

http://www.w3.org/2001/XMLSchema#string

Lisabianca Bottero

http://www.w3.org/2001/XMLSchema#string

M Cristina Errico

http://www.w3.org/2001/XMLSchema#string

Marina Petrini

http://www.w3.org/2001/XMLSchema#string

Mario P Colombo

http://www.w3.org/2001/XMLSchema#string

Mauro Biffoni

http://www.w3.org/2001/XMLSchema#string

P304

2745-2754

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-07-2538

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

68

http://www.w3.org/2001/XMLSchema#string

P577

2008-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5436118

http://www.w3.org/2001/XMLSchema#string

P698

18417445

http://www.w3.org/2001/XMLSchema#string

P921